OKLAHOMA city, 22 February 2011/PRNewswire/--Graymark health Inc. (Nasdaq: GRMH-News), the nation's second largest provider of services for diagnostic sleep and innovator in the comprehensive care of those sleep apnea (Through), carried out 225% year over year increase of patients resupply shipments in January, entry level, which is typically a slow month.
In January Graymark shipped 659 re-supply parts connected with their machines for continuous positive airway pressure (CPAP) and also realized an increase in the number of sleep studies, carried out through programmes increased margin of terrain. The number of settings for the sleep therapy, also increased from January 2010.
The re-supply part of Graymark business is a recurring revenue model. Patients, according to their devices, CPAP receive four deliveries of the constituent parts of the year.
Of Graymark effectively five clinical approach to the management of sleep disorders includes convenient referral process, accurate and timely assessment, diagnosis, treatment and long-term tracking can increase patient compliance. All steps shall be managed by a board certified sleep medicine doctor. By more fully integrating the processes of diagnosis and treatment, Graymark significantly improved patient compliance with CPAP care and overall management of the disease.
"This entry January demonstrated the moment of our model of comprehensive care," says Stanton Nelson, Chairman and CEO of Graymark healthcare. "The increasing rates of CPAP time contracts and higher margin agreements are key barometers that show we successfully provide timely and high quality sleep management programmes".
"We improved our platform measures the Board regardless of January is usually the most difficult because of the patient deductibles," adds Nelson. "These results to our Benchmark and verification of the continued success of our strategy of organic growth of fast-growing market for management of sleep".
Graymark is also expected to benefit from strengthening the entire market for disorder of sleep. 2010 Frost & Sullivan studies cost estimates for sleep apnea products to grow at a compounded rate of 13% and amounted to 5.3 billion dollars by 2014.
Graymark healthcare for
In Oklahoma City, Okla., Graymark Healthcare Inc. (Nasdaq: GRMH-News) is the second largest provider of "solutions for management of sleep. In addition to the diagnosis and treatment of more than 80 sleep disorders, the company specializes in comprehensive care of those Sleep Apnea (Through). Graymark offers its services through 98 dream laboratories in the United States, including the autonomous or facilities of the IDTF, rural terrain sites and a hospital or provider agreements. For more information, visit www.graymarkhealthcare.com.
Important warnings on forward looking statements
This press release may contain forward-looking statements that are based on current expectations, forecasts and assumptions of the company. Forward-looking statements involve risks and uncertainties that could cause actual outcomes and results to differ materially from expectations, forecasts and assumptions of the company. These risks and uncertainties include risks and uncertainties not in control of the company, including, without limitation, the current economic climate and other risks and uncertainties, including enumerated and described in the company's filings with the Securities and Exchange Commission, which filings are available on the SEC website at www.sec.gov. Unless otherwise required by law, company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
SleepApneaDisorder/[Press Release]/OKLAHOMA CITY/Graymark Healthcare, Inc. has been concluded previously announced the sale of substantially all the assets of its retail pharmacy ApothecaryRx is Walgreens co. ApothecaryRx operated 18 pharmacies in five States.